Overview

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of acarbose in comparison with voglibose in type 2 diabetic patients whose blood glucose levels were inadequately controlled with insulin glargine alone or in combination with metformin.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Acarbose
Insulin
Insulin Glargine
Insulin, Globin Zinc
Metformin
Voglibose